STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] ARTIVION, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Morgan Stanley filed Schedule 13G/A (Amendment No. 2) reporting beneficial ownership of 2,074,975 shares of Artivion, Inc. (AORT) common stock, representing 4.4% of the class as of the reporting event dated 09/30/2025. The filing states Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class.

The filing lists shared voting power: 208,344 shares and shared dispositive power: 2,074,975 shares, with 0 shares under sole voting or dispositive power. The certification indicates the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive
  • None.
Negative
  • None.

Insights

Stake reported at 4.4%; below the 5% threshold.

Morgan Stanley reports beneficial ownership of 2,074,975 Artivion shares, equal to 4.4%. This indicates a passive ownership posture within Schedule 13G parameters, with the event date of 09/30/2025.

The filing notes shared voting power: 208,344 and shared dispositive power: 2,074,975, and 0 sole powers. It also states Morgan Stanley has ceased to be the beneficial owner of more than five percent, signaling a threshold change under Section 13 rules.

Because this is an ownership disclosure rather than an operational change, the immediate investment impact is typically limited; any trading or liquidity effects depend on future holder decisions, which are not addressed in this excerpt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: As of the date hereof, Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class of securities.


SCHEDULE 13G



Morgan Stanley
Signature:Chris O'Hara
Name/Title:Authorized Signatory, Morgan Stanley
Date:11/07/2025

FAQ

What stake in Artivion (AORT) did Morgan Stanley report in this 13G/A?

Morgan Stanley reported beneficial ownership of 2,074,975 shares, representing 4.4% of Artivion’s common stock.

Did Morgan Stanley cross a key ownership threshold in Artivion (AORT)?

Yes. The filing states Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class.

What voting and dispositive powers did Morgan Stanley disclose for AORT?

It disclosed shared voting power: 208,344; shared dispositive power: 2,074,975; and 0 sole voting or dispositive power.

What is the event date associated with Morgan Stanley’s AORT ownership report?

The event date is 09/30/2025.

What certification did Morgan Stanley include in the 13G/A filing?

It certified the securities were acquired and are held in the ordinary course of business and not to change or influence control.

What type of filing is this for Artivion (AORT)?

A Schedule 13G/A (Amendment No. 2) reporting beneficial ownership.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.13B
42.36M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW